Primary Site >> Biliary tract Cancer
Gene >> MAPK14
| 1. | |||||||||||
| Journal: | Hepatology. 1999 Nov;30(5):1128-33. | ||||||||||
| Title: | Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. | ||||||||||
| Author: | Park, J|Tadlock, L|Gores, G J|Patel, T | ||||||||||
| PMID: | 10534331 | ||||||||||
| 2. | |||||||||||
| Journal: | Hepatology. 2001 Jan;33(1):43-51. | ||||||||||
| Title: | Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line. | ||||||||||
| Author: | Tadlock, L|Patel, T | ||||||||||
| PMID: | 11124819 | ||||||||||
| 3. | |||||||||||
| Journal: | Gastroenterology. 2002 Apr;122(4):985-93. | ||||||||||
| Title: | Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. | ||||||||||
| Author: | Yoon, Jung-Hwan|Higuchi, Hajime|Werneburg, Nathan W|Kaufmann, Scott H|Gores, Gregory J | ||||||||||
| PMID: | 11910351 | ||||||||||
| 4. | |||||||||||
| Journal: | Hepatology. 2002 Aug;36(2):363-73. | ||||||||||
| Title: | Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells. | ||||||||||
| Author: | Wu, Tong|Han, Chang|Lunz, John G 3rd|Michalopoulos, George|Shelhamer, James H|Demetris, A Jake | ||||||||||
| PMID: | 12143044 | ||||||||||
| 5. | |||||||||||
| Journal: | Hepatology. 2003 May;37(5):1122-9. | ||||||||||
| Title: | Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. | ||||||||||
| Author: | Tanaka, Shinji|Sugimachi, Keishi|Kameyama, Toshifumi|Maehara, Shin-Ichiro|Shirabe, Ken|Shimada, Mitsuo|Wands, Jack R|Maehara, Yoshihiko | ||||||||||
| PMID: | 12717393 | ||||||||||
| 6. | |||||||||||
| Journal: | Hepatology. 2003 Jul;38(1):158-66. | ||||||||||
| Title: | Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth. | ||||||||||
| Author: | Yamagiwa, Yoko|Marienfeld, Carla|Tadlock, Laura|Patel, Tushar | ||||||||||
| PMID: | 12829998 | ||||||||||
| 7. | |||||||||||
| Journal: | Am J Physiol Gastrointest Liver Physiol. 2004 Jun;286(6):G973-82. | ||||||||||
| Title: | Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. | ||||||||||
| Author: | Alpini, Gianfranco|Kanno, Noriatsu|Phinizy, Jo Lynne|Glaser, Shannon|Francis, Heather|Taffetani, Silvia|LeSage, Gene | ||||||||||
| PMID: | 14701718 | ||||||||||
| 8. | |||||||||||
| Journal: | Am J Physiol Cell Physiol. 2005 Oct;289(4):C971-81. | ||||||||||
| Title: | IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway. | ||||||||||
| Author: | Meng, Fanyin|Yamagiwa, Yoko|Taffetani, Silvia|Han, Jiahuai|Patel, Tushar | ||||||||||
| PMID: | 15917303 | ||||||||||
| 9. | |||||||||||
| Journal: | Int J Oncol. 2006 Apr;28(4):915-21. | ||||||||||
| Title: | The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines. | ||||||||||
| Author: | Miyata, Hideki|Sasaki, Tamito|Kuwahara, Kenichi|Serikawa, Masahiro|Chayama, Kazuaki | ||||||||||
| PMID: | 16525641 | ||||||||||
| 10. | |||||||||||
| Journal: | J Hepatol. 2006 Jun;44(6):1055-65. | ||||||||||
| Title: | Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes. | ||||||||||
| Author: | Meng, Fanyin|Yamagiwa, Yoko|Ueno, Yoshiyuki|Patel, Tushar | ||||||||||
| PMID: | 16469407 | ||||||||||
| 11. | |||||||||||
| Journal: | Life Sci. 2006 Apr 18;78(21):2494-502. | ||||||||||
| Title: | Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes. | ||||||||||
| Author: | Yamagiwa, Yoko|Meng, Fanyin|Patel, Tushar | ||||||||||
| PMID: | 16336976 | ||||||||||
| 12. | |||||||||||
| Journal: | Int J Cancer. 2010 May 15;126(10):2353-61. | ||||||||||
| Title: | p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion. | ||||||||||
| Author: | Tan, Felicia Li-Sher|Ooi, Aikseng|Huang, Dachuan|Wong, Jing Chii|Qian, Chao-Nan|Chao, Cora|Ooi, London|Tan, Yu-Meng|Chung, Alexander|Cheow, Peng-Chung|Zhang, Zhongfa|Petillo, David|Yang, Ximing J|Teh, Bin Tean | ||||||||||
| PMID: | 19816939 | ||||||||||
| 13. | |||||||||||
| Journal: | J Biol Chem. 2012 Nov 16;287(47):39812-23. | ||||||||||
| Title: | The tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells. | ||||||||||
| Author: | Dai, Rongyang|Li, Juanjuan|Fu, Jing|Chen, Yao|Wang, Ruoyu|Zhao, Xiaofang|Luo, Tao|Zhu, Junjie|Ren, Yibin|Cao, Jie|Qian, Youwen|Li, Ning|Wang, Hongyang | ||||||||||
| PMID: | 23024367 | ||||||||||
| 14. | |||||||||||
| Journal: | Cancer Sci. 2014 Aug;105(8):956-65. | ||||||||||
| Title: | MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer. | ||||||||||
| Author: | Zhou, Huading|Guo, Weijie|Zhao, Yingjun|Wang, Yifei|Zha, Ruopeng|Ding, Jie|Liang, Linhui|Yang, Guanghua|Chen, Zongyou|Ma, Baojin|Yin, Baobing | ||||||||||
| PMID: | 24903309 | ||||||||||
| 15. | |||||||||||
| Journal: | Cell Physiol Biochem. 2014;34(5):1711-22. | ||||||||||
| Title: | WWOX suppresses cell growth and induces cell apoptosis via inhibition of P38 nuclear translocation in cholangiocarcinoma. | ||||||||||
| Author: | Wang, Mei|Li, Yongmei|Wu, Meihong|Wang, Wei|Gong, Biao|Wang, Yajie | ||||||||||
| PMID: | 25502636 | ||||||||||
| 16. | |||||||||||
| Journal: | Cancer Sci. 2016 Jul;107(7):991-1000. | ||||||||||
| Title: | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. | ||||||||||
| Author: | Thanee, Malinee|Loilome, Watcharin|Techasen, Anchalee|Sugihara, Eiji|Okazaki, Shogo|Abe, Shinya|Ueda, Shiho|Masuko, Takashi|Namwat, Nisana|Khuntikeo, Narong|Titapun, Attapol|Pairojkul, Chawalit|Saya, Hideyuki|Yongvanit, Puangrat | ||||||||||
| PMID: | 27176078 | ||||||||||
| 17. | |||||||||||
| Journal: | Sci Rep. 2016 Jun 28;6:28833. | ||||||||||
| Title: | Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo. | ||||||||||
| Author: | Wang, Jiwen|Yao, Yanli|Ming, Yue|Shen, Sheng|Wu, Nan|Liu, Jiaqi|Liu, Han|Suo, Tao|Pan, Hongtao|Zhang, Dexiang|Ding, Kan|Liu, Houbao | ||||||||||
| PMID: | 27349455 | ||||||||||
| 18. | |||||||||||
| Journal: | Future Oncol. 2017 Oct;13(23):2053-2063. | ||||||||||
| Title: | S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway. | ||||||||||
| Author: | Zheng, Susu|Shen, Hujia|Jia, Qingan|Jing, Chuyu|Lin, Jiajia|Zhang, Meixia|Zhang, Xiaolei|Zhang, Boheng|Liu, Yinkun | ||||||||||
| PMID: | 28984474 | ||||||||||
| 19. | |||||||||||
| Journal: | Oncol Lett. 2018 Aug;16(2):1869-1875. | ||||||||||
| Title: | DUSP1 enhances the chemoresistance of gallbladder cancer via the modulation of the p38 pathway and DNA damage/repair system. | ||||||||||
| Author: | Fang, Jun|Ye, Zhimin|Gu, Feiying|Yan, Maohui|Lin, Qingren|Lin, Juan|Wang, Zhun|Xu, Yaping|Wang, Yuezhen | ||||||||||
| PMID: | 30008878 | ||||||||||
| 20. | |||||||||||
| Journal: | Mol Carcinog. 2018 Sep 4. | ||||||||||
| Title: | S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Zhang, Mei-Xia|Gan, Wei|Jing, Chu-Yu|Zheng, Su-Su|Yi, Yong|Zhang, Juan|Xu, Xin|Lin, Jia-Jia|Zhang, Bo-Heng|Qiu, Shuang-Jian | ||||||||||
| PMID: | 30182496 | ||||||||||
| 21. | |||||||||||
| Journal: | J Surg Res. 2018 Nov;231:116-125. | ||||||||||
| Title: | IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC. | ||||||||||
| Author: | Wang, Jian|Zhang, Zhan-Guo|Ding, Ze-Yang|Dong, Wei|Liang, Hui-Fang|Chu, Liang|Zhang, Bi-Xiang|Chen, Xiao-Ping | ||||||||||
| PMID: | 30278918 | ||||||||||